CONTRAVE: payments to doctors
Payments that named CONTRAVE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.3M
- Providers
- 19,785
- Transactions
- 56,989
- Average per transaction
- $23
The per-transaction average — $23 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 19,785 providers the average total is $67, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Currax Pharmaceuticals LLC | $1,229,138 | 92.3% |
| Nalpropion Pharmaceuticals LLC | $53,658 | 4.0% |
| Bausch Health US, LLC | $48,951 | 3.7% |
| Takeda Pharmaceuticals U.S.A., Inc. | $27 | 0.0% |